The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Preimplantation Genetic Diagnosis (PGD) Market Research Report 2025
Synopsis
The global Preimplantation Genetic Diagnosis (PGD) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Preimplantation Genetic Diagnosis (PGD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preimplantation Genetic Diagnosis (PGD).
Report Scope
The Preimplantation Genetic Diagnosis (PGD) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preimplantation Genetic Diagnosis (PGD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preimplantation Genetic Diagnosis (PGD) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Thermo Fisher
Agilent Technologies
PerkinElmer
Coopersurgical
Abbott Laboratories
Natera
Takara Bio
Oxford Gene Technology
Yikon Genomics
Progenesis
Beijing Genomics Institute
Invitae
Invicta Genetics
Combimatrix
Genea Limited
Bioarray
Quest Diagnostics
Segment by Type
Chromosomal Abnormalities
Gender Selection
X-linked Diseases
Aneuploidy
Single Gene Disorders
Others
Segment by Application
Maternity Centers & Fertility Clinics
Hospitals, Diagnostic Labs, and Service Providers
Research Laboratories & Academic Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preimplantation Genetic Diagnosis (PGD) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Preimplantation Genetic Diagnosis (PGD) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Preimplantation Genetic Diagnosis (PGD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preimplantation Genetic Diagnosis (PGD).
Report Scope
The Preimplantation Genetic Diagnosis (PGD) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preimplantation Genetic Diagnosis (PGD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preimplantation Genetic Diagnosis (PGD) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Thermo Fisher
Agilent Technologies
PerkinElmer
Coopersurgical
Abbott Laboratories
Natera
Takara Bio
Oxford Gene Technology
Yikon Genomics
Progenesis
Beijing Genomics Institute
Invitae
Invicta Genetics
Combimatrix
Genea Limited
Bioarray
Quest Diagnostics
Segment by Type
Chromosomal Abnormalities
Gender Selection
X-linked Diseases
Aneuploidy
Single Gene Disorders
Others
Segment by Application
Maternity Centers & Fertility Clinics
Hospitals, Diagnostic Labs, and Service Providers
Research Laboratories & Academic Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preimplantation Genetic Diagnosis (PGD) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chromosomal Abnormalities
1.2.3 Gender Selection
1.2.4 X-linked Diseases
1.2.5 Aneuploidy
1.2.6 Single Gene Disorders
1.2.7 Others
1.3 Market by Application
1.3.1 Global Preimplantation Genetic Diagnosis (PGD) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Maternity Centers & Fertility Clinics
1.3.3 Hospitals, Diagnostic Labs, and Service Providers
1.3.4 Research Laboratories & Academic Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preimplantation Genetic Diagnosis (PGD) Market Perspective (2019-2030)
2.2 Preimplantation Genetic Diagnosis (PGD) Growth Trends by Region
2.2.1 Global Preimplantation Genetic Diagnosis (PGD) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Preimplantation Genetic Diagnosis (PGD) Historic Market Size by Region (2019-2024)
2.2.3 Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Region (2025-2030)
2.3 Preimplantation Genetic Diagnosis (PGD) Market Dynamics
2.3.1 Preimplantation Genetic Diagnosis (PGD) Industry Trends
2.3.2 Preimplantation Genetic Diagnosis (PGD) Market Drivers
2.3.3 Preimplantation Genetic Diagnosis (PGD) Market Challenges
2.3.4 Preimplantation Genetic Diagnosis (PGD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preimplantation Genetic Diagnosis (PGD) Players by Revenue
3.1.1 Global Top Preimplantation Genetic Diagnosis (PGD) Players by Revenue (2019-2024)
3.1.2 Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Players (2019-2024)
3.2 Global Preimplantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preimplantation Genetic Diagnosis (PGD) Revenue
3.4 Global Preimplantation Genetic Diagnosis (PGD) Market Concentration Ratio
3.4.1 Global Preimplantation Genetic Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preimplantation Genetic Diagnosis (PGD) Revenue in 2023
3.5 Preimplantation Genetic Diagnosis (PGD) Key Players Head office and Area Served
3.6 Key Players Preimplantation Genetic Diagnosis (PGD) Product Solution and Service
3.7 Date of Enter into Preimplantation Genetic Diagnosis (PGD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preimplantation Genetic Diagnosis (PGD) Breakdown Data by Type
4.1 Global Preimplantation Genetic Diagnosis (PGD) Historic Market Size by Type (2019-2024)
4.2 Global Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2025-2030)
5 Preimplantation Genetic Diagnosis (PGD) Breakdown Data by Application
5.1 Global Preimplantation Genetic Diagnosis (PGD) Historic Market Size by Application (2019-2024)
5.2 Global Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Preimplantation Genetic Diagnosis (PGD) Market Size (2019-2030)
6.2 North America Preimplantation Genetic Diagnosis (PGD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2019-2024)
6.4 North America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preimplantation Genetic Diagnosis (PGD) Market Size (2019-2030)
7.2 Europe Preimplantation Genetic Diagnosis (PGD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2019-2024)
7.4 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size (2019-2030)
8.2 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2019-2024)
8.4 Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preimplantation Genetic Diagnosis (PGD) Market Size (2019-2030)
9.2 Latin America Preimplantation Genetic Diagnosis (PGD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2019-2024)
9.4 Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size (2019-2030)
10.2 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2019-2024)
10.4 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Preimplantation Genetic Diagnosis (PGD) Introduction
11.1.4 Illumina Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Detail
11.2.2 Thermo Fisher Business Overview
11.2.3 Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Introduction
11.2.4 Thermo Fisher Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
11.2.5 Thermo Fisher Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Detail
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Introduction
11.3.4 Agilent Technologies Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
11.3.5 Agilent Technologies Recent Development
11.4 PerkinElmer
11.4.1 PerkinElmer Company Detail
11.4.2 PerkinElmer Business Overview
11.4.3 PerkinElmer Preimplantation Genetic Diagnosis (PGD) Introduction
11.4.4 PerkinElmer Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
11.4.5 PerkinElmer Recent Development
11.5 Coopersurgical
11.5.1 Coopersurgical Company Detail
11.5.2 Coopersurgical Business Overview
11.5.3 Coopersurgical Preimplantation Genetic Diagnosis (PGD) Introduction
11.5.4 Coopersurgical Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
11.5.5 Coopersurgical Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Detail
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Introduction
11.6.4 Abbott Laboratories Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
11.6.5 Abbott Laboratories Recent Development
11.7 Natera
11.7.1 Natera Company Detail
11.7.2 Natera Business Overview
11.7.3 Natera Preimplantation Genetic Diagnosis (PGD) Introduction
11.7.4 Natera Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
11.7.5 Natera Recent Development
11.8 Takara Bio
11.8.1 Takara Bio Company Detail
11.8.2 Takara Bio Business Overview
11.8.3 Takara Bio Preimplantation Genetic Diagnosis (PGD) Introduction
11.8.4 Takara Bio Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
11.8.5 Takara Bio Recent Development
11.9 Oxford Gene Technology
11.9.1 Oxford Gene Technology Company Detail
11.9.2 Oxford Gene Technology Business Overview
11.9.3 Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Introduction
11.9.4 Oxford Gene Technology Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
11.9.5 Oxford Gene Technology Recent Development
11.10 Yikon Genomics
11.10.1 Yikon Genomics Company Detail
11.10.2 Yikon Genomics Business Overview
11.10.3 Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Introduction
11.10.4 Yikon Genomics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
11.10.5 Yikon Genomics Recent Development
11.11 Progenesis
11.11.1 Progenesis Company Detail
11.11.2 Progenesis Business Overview
11.11.3 Progenesis Preimplantation Genetic Diagnosis (PGD) Introduction
11.11.4 Progenesis Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
11.11.5 Progenesis Recent Development
11.12 Beijing Genomics Institute
11.12.1 Beijing Genomics Institute Company Detail
11.12.2 Beijing Genomics Institute Business Overview
11.12.3 Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Introduction
11.12.4 Beijing Genomics Institute Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
11.12.5 Beijing Genomics Institute Recent Development
11.13 Invitae
11.13.1 Invitae Company Detail
11.13.2 Invitae Business Overview
11.13.3 Invitae Preimplantation Genetic Diagnosis (PGD) Introduction
11.13.4 Invitae Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
11.13.5 Invitae Recent Development
11.14 Invicta Genetics
11.14.1 Invicta Genetics Company Detail
11.14.2 Invicta Genetics Business Overview
11.14.3 Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Introduction
11.14.4 Invicta Genetics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
11.14.5 Invicta Genetics Recent Development
11.15 Combimatrix
11.15.1 Combimatrix Company Detail
11.15.2 Combimatrix Business Overview
11.15.3 Combimatrix Preimplantation Genetic Diagnosis (PGD) Introduction
11.15.4 Combimatrix Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
11.15.5 Combimatrix Recent Development
11.16 Genea Limited
11.16.1 Genea Limited Company Detail
11.16.2 Genea Limited Business Overview
11.16.3 Genea Limited Preimplantation Genetic Diagnosis (PGD) Introduction
11.16.4 Genea Limited Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
11.16.5 Genea Limited Recent Development
11.17 Bioarray
11.17.1 Bioarray Company Detail
11.17.2 Bioarray Business Overview
11.17.3 Bioarray Preimplantation Genetic Diagnosis (PGD) Introduction
11.17.4 Bioarray Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
11.17.5 Bioarray Recent Development
11.18 Quest Diagnostics
11.18.1 Quest Diagnostics Company Detail
11.18.2 Quest Diagnostics Business Overview
11.18.3 Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Introduction
11.18.4 Quest Diagnostics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
11.18.5 Quest Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Chromosomal Abnormalities
Table 3. Key Players of Gender Selection
Table 4. Key Players of X-linked Diseases
Table 5. Key Players of Aneuploidy
Table 6. Key Players of Single Gene Disorders
Table 7. Key Players of Others
Table 8. Global Preimplantation Genetic Diagnosis (PGD) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Preimplantation Genetic Diagnosis (PGD) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Region (2019-2024)
Table 12. Global Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Region (2025-2030)
Table 14. Preimplantation Genetic Diagnosis (PGD) Market Trends
Table 15. Preimplantation Genetic Diagnosis (PGD) Market Drivers
Table 16. Preimplantation Genetic Diagnosis (PGD) Market Challenges
Table 17. Preimplantation Genetic Diagnosis (PGD) Market Restraints
Table 18. Global Preimplantation Genetic Diagnosis (PGD) Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Players (2019-2024)
Table 20. Global Top Preimplantation Genetic Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetic Diagnosis (PGD) as of 2023)
Table 21. Ranking of Global Top Preimplantation Genetic Diagnosis (PGD) Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Preimplantation Genetic Diagnosis (PGD) Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Preimplantation Genetic Diagnosis (PGD) Product Solution and Service
Table 25. Date of Enter into Preimplantation Genetic Diagnosis (PGD) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2019-2024)
Table 29. Global Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2025-2030)
Table 31. Global Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Application (2019-2024)
Table 33. Global Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Application (2025-2030)
Table 35. North America Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2025-2030) & (US$ Million)
Table 50. Illumina Company Detail
Table 51. Illumina Business Overview
Table 52. Illumina Preimplantation Genetic Diagnosis (PGD) Product
Table 53. Illumina Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 54. Illumina Recent Development
Table 55. Thermo Fisher Company Detail
Table 56. Thermo Fisher Business Overview
Table 57. Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Product
Table 58. Thermo Fisher Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 59. Thermo Fisher Recent Development
Table 60. Agilent Technologies Company Detail
Table 61. Agilent Technologies Business Overview
Table 62. Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Product
Table 63. Agilent Technologies Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 64. Agilent Technologies Recent Development
Table 65. PerkinElmer Company Detail
Table 66. PerkinElmer Business Overview
Table 67. PerkinElmer Preimplantation Genetic Diagnosis (PGD) Product
Table 68. PerkinElmer Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 69. PerkinElmer Recent Development
Table 70. Coopersurgical Company Detail
Table 71. Coopersurgical Business Overview
Table 72. Coopersurgical Preimplantation Genetic Diagnosis (PGD) Product
Table 73. Coopersurgical Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 74. Coopersurgical Recent Development
Table 75. Abbott Laboratories Company Detail
Table 76. Abbott Laboratories Business Overview
Table 77. Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Product
Table 78. Abbott Laboratories Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 79. Abbott Laboratories Recent Development
Table 80. Natera Company Detail
Table 81. Natera Business Overview
Table 82. Natera Preimplantation Genetic Diagnosis (PGD) Product
Table 83. Natera Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 84. Natera Recent Development
Table 85. Takara Bio Company Detail
Table 86. Takara Bio Business Overview
Table 87. Takara Bio Preimplantation Genetic Diagnosis (PGD) Product
Table 88. Takara Bio Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 89. Takara Bio Recent Development
Table 90. Oxford Gene Technology Company Detail
Table 91. Oxford Gene Technology Business Overview
Table 92. Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Product
Table 93. Oxford Gene Technology Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 94. Oxford Gene Technology Recent Development
Table 95. Yikon Genomics Company Detail
Table 96. Yikon Genomics Business Overview
Table 97. Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Product
Table 98. Yikon Genomics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 99. Yikon Genomics Recent Development
Table 100. Progenesis Company Detail
Table 101. Progenesis Business Overview
Table 102. Progenesis Preimplantation Genetic Diagnosis (PGD) Product
Table 103. Progenesis Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 104. Progenesis Recent Development
Table 105. Beijing Genomics Institute Company Detail
Table 106. Beijing Genomics Institute Business Overview
Table 107. Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Product
Table 108. Beijing Genomics Institute Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 109. Beijing Genomics Institute Recent Development
Table 110. Invitae Company Detail
Table 111. Invitae Business Overview
Table 112. Invitae Preimplantation Genetic Diagnosis (PGD) Product
Table 113. Invitae Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 114. Invitae Recent Development
Table 115. Invicta Genetics Company Detail
Table 116. Invicta Genetics Business Overview
Table 117. Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Product
Table 118. Invicta Genetics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 119. Invicta Genetics Recent Development
Table 120. Combimatrix Company Detail
Table 121. Combimatrix Business Overview
Table 122. Combimatrix Preimplantation Genetic Diagnosis (PGD) Product
Table 123. Combimatrix Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 124. Combimatrix Recent Development
Table 125. Genea Limited Company Detail
Table 126. Genea Limited Business Overview
Table 127. Genea Limited Preimplantation Genetic Diagnosis (PGD) Product
Table 128. Genea Limited Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 129. Genea Limited Recent Development
Table 130. Bioarray Company Detail
Table 131. Bioarray Business Overview
Table 132. Bioarray Preimplantation Genetic Diagnosis (PGD) Product
Table 133. Bioarray Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 134. Bioarray Recent Development
Table 135. Quest Diagnostics Company Detail
Table 136. Quest Diagnostics Business Overview
Table 137. Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Product
Table 138. Quest Diagnostics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
Table 139. Quest Diagnostics Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preimplantation Genetic Diagnosis (PGD) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Type: 2023 VS 2030
Figure 3. Chromosomal Abnormalities Features
Figure 4. Gender Selection Features
Figure 5. X-linked Diseases Features
Figure 6. Aneuploidy Features
Figure 7. Single Gene Disorders Features
Figure 8. Others Features
Figure 9. Global Preimplantation Genetic Diagnosis (PGD) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Application: 2023 VS 2030
Figure 11. Maternity Centers & Fertility Clinics Case Studies
Figure 12. Hospitals, Diagnostic Labs, and Service Providers Case Studies
Figure 13. Research Laboratories & Academic Institutes Case Studies
Figure 14. Preimplantation Genetic Diagnosis (PGD) Report Years Considered
Figure 15. Global Preimplantation Genetic Diagnosis (PGD) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Preimplantation Genetic Diagnosis (PGD) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Region: 2023 VS 2030
Figure 18. Global Preimplantation Genetic Diagnosis (PGD) Market Share by Players in 2023
Figure 19. Global Top Preimplantation Genetic Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetic Diagnosis (PGD) as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Preimplantation Genetic Diagnosis (PGD) Revenue in 2023
Figure 21. North America Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Preimplantation Genetic Diagnosis (PGD) Market Share by Country (2019-2030)
Figure 23. United States Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Preimplantation Genetic Diagnosis (PGD) Market Share by Country (2019-2030)
Figure 27. Germany Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Preimplantation Genetic Diagnosis (PGD) Market Share by Region (2019-2030)
Figure 35. China Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Preimplantation Genetic Diagnosis (PGD) Market Share by Country (2019-2030)
Figure 43. Mexico Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Share by Country (2019-2030)
Figure 47. Turkey Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Preimplantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Illumina Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
Figure 50. Thermo Fisher Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
Figure 51. Agilent Technologies Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
Figure 52. PerkinElmer Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
Figure 53. Coopersurgical Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
Figure 54. Abbott Laboratories Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
Figure 55. Natera Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
Figure 56. Takara Bio Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
Figure 57. Oxford Gene Technology Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
Figure 58. Yikon Genomics Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
Figure 59. Progenesis Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
Figure 60. Beijing Genomics Institute Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
Figure 61. Invitae Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
Figure 62. Invicta Genetics Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
Figure 63. Combimatrix Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
Figure 64. Genea Limited Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
Figure 65. Bioarray Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
Figure 66. Quest Diagnostics Revenue Growth Rate in Preimplantation Genetic Diagnosis (PGD) Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
